Main Line Health significantly improved its financial performance in fiscal 2024, reports John George for the Philadelphia Business Journal.

The health group reduced its operating loss by half, according to audited financial statements. They reported an operating loss of $61.1 million for the year ending June 30, down from a $125.3 million deficit in the previous year. 

Operating revenue climbed to $2.29 billion, marking a 9% increase from the $2.1 billion earned in fiscal 2023. Overall revenue also rose by 9%, reaching nearly $2.4 billion. Main Line Health posted a net income of $62 million, boosted by $126.4 million in non-operating investment income, a significant turnaround from the prior year’s net loss of $36.6 million.

Leigh Ehrlich, CFO of Main Line Health, attributed this improvement to renegotiated payer contracts that better align with inflationary pressures on expenses. She also cited measures aimed at reducing premium labor costs. “We are continuing to look for efficiencies in how we deliver care without compromising safety and quality for our patients,” Ehrlich noted.

The health system is considering expanding its ambulatory footprint to enhance patient access, although specific plans for new care centers have not been disclosed. Currently, Main Line Health operates multi-specialty outpatient health centers in locations including Broomall, Collegeville, and Newtown Square.

Main Line Health oversees four acute care hospitals: Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital, and Riddle Hospital. In addition, it operates Bryn Mawr Rehabilitation Hospital and Mirmont Treatment Center, and collaborates with Jefferson Health and Humana in the Delaware Valley ACO.

Other regional health systems have also reported impressive financial recoveries, reflecting a broader trend of improving balance sheets across the sector in fiscal 2024.

Read more about Main Line Health at the Philadelphia Business Journal.

———————————————